ASYMMETRIC DIMETHYL ARGININE AND UROMODULININ THE CHRONIC KIDNEY DISEASE
Noor Ali
The Iraqi Journal of Medical Sciences · 2019
doi:10.22578/ijms.17.3-4.1 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Asymmetric dimethyl arginine, symmetric dimethyl arginine and uromodulin used as early biomarkers of diagnosis renal diseases. The early stages side effects of inveterate kidney malady are ordinarily not clear. Noteworthy decrease of the kidney work is the primary self-evident sign of infection. On the off chance that analyzed early stages 1 to 3, the movement of unremitting kidney infection can be changed and complications diminished. In stages 4 and 5 broad kidney harm is watched, which as a rule comes about in end-stage renal disappointment. Keywords:Symmetric Dimethyl arginine, uromodulin and kidney Citation:Ali NM. Asymmetric dimethyl arginine and uromodulin in the chronic kidney disease. Iraqi JMS. 2019; 17(3&4): 166-167. doi: 10.22578/IJMS.17.3&4.1
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.